VisionQuest Biomedical LLC (VisionQuest) is a medical device company that develops medical imaging tools for the diagnostic services. The company’s products include EYESTAR, retinal image quality analyzer, ASPIRE, and diabetic neuropathy detection imaging systems. Its EYESTAR product is a total eye disease screening program package and ASPIRE is a retinal camera device that detects cerebral malarial retinopathy. VisionQuest's imaging analysis and technology is used in ultrasound, ophthalmology, and infrared imaging. The company provides its products for early detection and diagnosis of chronic diseases such as diabetic retinopathy, age-related macular degeneration, glaucoma, and cardiovascular disease. It also offers research and development services. VisionQuest is headquartered in Albuquerque, New Mexico, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company VisionQuest Biomedical LLC
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- VisionQuest Biomedical LLC Company Overview
- VisionQuest Biomedical LLC Company Snapshot
- VisionQuest Biomedical LLC Pipeline Products and Ongoing Clinical Trials Overview
- VisionQuest Biomedical LLC - Pipeline Analysis Overview
- VisionQuest Biomedical LLC - Key Facts
- VisionQuest Biomedical LLC - Major Products and Services
- VisionQuest Biomedical LLC Pipeline Products by Development Stage
- VisionQuest Biomedical LLC Pipeline Products Overview
- AI-Based Device - Malarial Retinopathy
- AI-Based Device - Malarial Retinopathy Product Overview
- Aspire
- Aspire Product Overview
- CARV First Reader System
- CARV First Reader System Product Overview
- CARV Second Reader System
- CARV Second Reader System Product Overview
- ConQuest
- ConQuest Product Overview
- DR-RACS
- DR-RACS Product Overview
- DR-SCRN
- DR-SCRN Product Overview
- Eyestar
- Eyestar Product Overview
- EyeStar-BIO
- EyeStar-BIO Product Overview
- Functional Scanning Laser Ophthalmoscope
- Functional Scanning Laser Ophthalmoscope Product Overview
- i-RxCam
- i-RxCam Product Overview
- i-RxTherm
- i-RxTherm Product Overview
- Neoscan-Assist
- Neoscan-Assist Product Overview
- Real-Time fMRI
- Real-Time fMRI Product Overview
- VisionQuest Biomedical LLC - Key Competitors
- VisionQuest Biomedical LLC - Key Employees
- VisionQuest Biomedical LLC - Locations And Subsidiaries
- Head Office
- Recent Developments
- VisionQuest Biomedical LLC, Recent Developments
- Jun 15, 2021: VisionQuest uses artificial intelligence to screen 40,000 patients for diabetic retinopathy
- Jun 09, 2021: VisionQuest receives a $2M NIH grant to commercialize an artificial intelligence system used to improve and save the lives of African children affected with malaria
- Jan 04, 2021: VisionQuest Biomedical obtains FDA approval for Image Quality Analyzer (IQA)
- Dec 30, 2020: VisionQuest Biomedical gains FDA 510(k) clearance for the Image Quality Analyzer software
- Aug 12, 2020: VisionQuest Biomedical’s EyeStar passes the 30,000-patient milestone for diabetic retinopathy screening using artificial intelligence
- Jun 23, 2020: VisionQuest Biomedical to participate in virtual exhibit at the World Ophthalmology Congress 2020
- Jan 21, 2019: VisionQuest joins Retina Global and Volk Optical for clinical study in Bolivia
- Sep 10, 2018: VisionQuest Announces Leadership Promotions and Formation of Advisory Board
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- VisionQuest Biomedical LLC Pipeline Products and Ongoing Clinical Trials Overview
- VisionQuest Biomedical LLC Pipeline Products by Equipment Type
- VisionQuest Biomedical LLC Pipeline Products by Indication
- VisionQuest Biomedical LLC, Key Facts
- VisionQuest Biomedical LLC, Major Products and Services
- VisionQuest Biomedical LLC Number of Pipeline Products by Development Stage
- VisionQuest Biomedical LLC Pipeline Products Summary by Development Stage
- AI-Based Device - Malarial Retinopathy - Product Status
- AI-Based Device - Malarial Retinopathy - Product Description
- Aspire - Product Status
- Aspire - Product Description
- CARV First Reader System - Product Status
- CARV First Reader System - Product Description
- CARV Second Reader System - Product Status
- CARV Second Reader System - Product Description
- ConQuest - Product Status
- ConQuest - Product Description
- DR-RACS - Product Status
- DR-RACS - Product Description
- DR-SCRN - Product Status
- DR-SCRN - Product Description
- Eyestar - Product Status
- Eyestar - Product Description
- EyeStar-BIO - Product Status
- EyeStar-BIO - Product Description
- Functional Scanning Laser Ophthalmoscope - Product Status
- Functional Scanning Laser Ophthalmoscope - Product Description
- i-RxCam - Product Status
- i-RxCam - Product Description
- i-RxTherm - Product Status
- i-RxTherm - Product Description
- Neoscan-Assist - Product Status
- Neoscan-Assist - Product Description
- Real-Time fMRI - Product Status
- Real-Time fMRI - Product Description
- VisionQuest Biomedical LLC, Key Employees
- Glossary
- VisionQuest Biomedical LLC Pipeline Products by Equipment Type
- VisionQuest Biomedical LLC Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 7 Medical Systems LLC
- Biodex Medical Systems Inc
- Coeur Inc
- Altrum Technologies, Inc.
- BRIT Systems Inc
